Clinical Trial Update: Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing two basal insulins in adults with Type 2 diabetes taking oral diabetes medicines and exenatide; results were posted December 14, 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2010-12-14